AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Viatris' Q3 growth rate slowed across product categories and regions sequentially. The company's revenue grew 10% YoY, but the pace of growth slowed down compared to the previous quarter. The slowdown was seen in all product categories and regions, with the exception of the respiratory portfolio in the US.

Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet